Sign in
Taking peopleNo phase

Early-Onset Myopia Intervention Project

Key facts

Who runs it
Shanghai Eye Disease Prevention and Treatment Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
508 people, planned
Started
1 Jun 2025
Expected to end
31 May 2028
Type of study
Interventional, 4 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • 0.01% atropine eye drops
  • 0.05% atropine eye drops
  • Spectacle lenses with highly aspherical lenslets
Record updated
16 September 2025

Who can take part

Age
3 years to 6 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • Age 3-6 years, gender unrestricted
  • Bilateral cycloplegic spherical equivalent (SE) ≤ +0.75 D, astigmatism ≤-2.5 D, anisometropia ≤2.5 D
  • Best corrected visual acuity: ≥0.5 for ages 3-5, ≥0.7 for age 6
  • Accept regular follow-up, written informed consent from guardians, verbal informed consent from children
  • Possess normal thinking and language communication skills, and can actively cooperate to wear spectacles as required

Who cannot take part

  • Current or previous use of other treatments for myopia intervention, such as pharmacological (atropine) and optical (orthokeratology lenses or DIMS spectacle lenses) approaches, interrupt use for at least 4 weeks
  • Existence of strabismus or amblyopia or other binocular vision abnormalities, accommodation dysfunction, cataract and history of eye surgery
  • Any ocular or systemic disease that may affect vision and refractive development (e.g., Keratoconus, Marfan syndrome, retinopathy of prematurity, etc.)
  • Allergy or contraindication to cycloplegic drugs
  • Epilepsy or other mental disorders unable to expressing consent
  • Other conditions deemed unsuitable for participation by the researcher

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Myopia or pre-myopia

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The prevalence of myopia among children has been increasing year by year, which has become a globle public health issue. Studies have shown that defocusing lenses and atroping eyedrops can control the progression of myopia, but there is little evidence of its efficacy in myopia intervention of young pre-schoolers who will face a greater risk of progression to high myopia later in life. Therefore, this study aims to evaluate the effectiveness and safety of spectacle lenses with highly aspherical lenslets (Essilor's Stellest) , as well as 0.01% and 0.05% low concentration atropine eyedrops in myopia intervention among young children aged 3-6.

The 4 groups in the trial

  • No InterventionNo study treatment, for comparison

    No intervention for myopia control

  • Spectacle Lenses with Highly Aspherical LensletsTreatment being tested

    Wearing spectacle lenses with highly aspherical lenslets for myopia control

  • 0.01% AtropineTreatment being tested

    Nightly use of 0.01% atropine eyedrops for myopia control

    Treatment: 0.01% atropine eye drops

  • 0.05% AtropineTreatment being tested

    Nightly use of 0.05% atropine eyedrops for myopia control

    Treatment: 0.05% atropine eye drops

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Project on Myopia Surveillance and Intervention Services for Preschool Children in Shanghai
Criteria questions
Built from NCT07176949, who can take part
Record updated
16 September 2025